Latest SEC Filings

PUMA BIOTECHNOLOGY, INC.Puma Biotechnology Reports $56.5 Million Revenue for Q2 2026, Net Income Increases to $8.2 Million

FIRST BANCORP /NC/First Bancorp Reports 31.5% Increase in Net Income for Q2 and First Half of 2026

Kinetik Holdings Inc.Kinetik Holdings Inc. Reports 36% Revenue Growth to $581.4 Million in Latest Quarter

UNIVERSAL TECHNICAL INSTITUTE INCUniversal Technical Institute Reports 7.2% Revenue Growth but Declining Profitability in Q3 Fiscal 2026

Ark 21Shares Bitcoin ETFARK 21Shares Bitcoin ETF Reports 42.84% Decline in Net Assets for Quarter Ending June 30, 2026

Fortress Value Acquisition Corp. VFortress Value Acquisition Corp. V Reports Q2 2026 Financial Results with $1.7M Net Income

Clarus CorpClarus Corporation Reports Modest Sales Increase and Significant Gross Profit Growth in Q2 2026

TFS Financial CORPTFS Financial Corporation Reports 41.9% Increase in Quarterly Net Income

Krispy Kreme, Inc.Krispy Kreme Reports 12.8% Revenue Decline in Q2 Fiscal 2026, Net Loss Reduced by 95.3%

Simpson Manufacturing Co., Inc.Simpson Manufacturing Reports 6.3% Revenue Growth in Q2 2026

SpyGlass Pharma, Inc.SpyGlass Pharma Reports $19.9 Million Net Loss in Latest Quarter, IPO Boosts Cash Reserves

Braemar Hotels & Resorts Inc.Braemar Hotels & Resorts Reports $7M Net Income Turnaround, Plans Self-Management Transition

Verrica Pharmaceuticals Inc.Verrica Pharmaceuticals Reports 54% Revenue Decline and $13.2 Million Net Loss in Q2 2026

BECTON DICKINSON & COBecton, Dickinson and Company Reports 5.4% Revenue Growth in Q3 2026

SANUWAVE Health, Inc.SANUWAVE Health Reports Q2 2026 Revenue Decline and Net Loss

FRIEDMAN INDUSTRIES INCFriedman Industries Reports Significant Financial Growth with $239.97 Million in Net Sales

Oncology Institute, Inc.Starling Oncology Reports 34.6% Revenue Growth to $161.3 Million in Q2 2026

CARRIAGE SERVICES INCCarriage Services Reports Slight Revenue Increase but Decline in Net Income for Q2 2026

SUIC Worldwide Holdings Ltd.SUIC Worldwide Holdings Reports Revenue Growth and Strategic Acquisition Amid Ongoing Losses

Corbus Pharmaceuticals Holdings, Inc.Corbus Pharmaceuticals Reports $35M Net Loss in Q2 2026, Increases R&D Spending

KLA CORPKLA Corporation Reports 12% Revenue Growth to $13.58 Billion for Fiscal Year Ending June 30, 2026

MERCER INTERNATIONAL INC.Mercer International Reports $75.98 Million Net Loss in Q2 2026, Revenue Increases to $460.3 Million

Mativ Holdings, Inc.Mativ Holdings Reports Increased Net Sales and Profitability in Q2 2026

ICU MEDICAL INC/DEICU Medical Reports $551.7 Million Revenue in Q2 2026, Net Income Declines

INGLES MARKETS INCIngles Markets Reports Modest Sales Growth and Increased Net Income for Third Quarter